Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Nasal apomorphine set to enter phase I trials for erectile dysfunction

June 7, 2002

IPD-1151T may be preferable to other drugs in the treatment of interstitial cystitis

June 6, 2002

A possible role for the nicotinic agonist epibatidine in neurogenic voiding dysfunction

June 6, 2002

KW-7158 depresses bladder hyperactivity through afferent pathways

June 6, 2002

Lilly Icos presents novel phosphodiesterase inhibitors

June 6, 2002

Potential of phytoestrogens in the therapy of overactive bladder

June 5, 2002

Schering presents PDE5 inhibitors for erectile dysfunction

June 4, 2002

Fujisawa patents series for use in urinary incontinence

June 3, 2002

Inhibitors of phosphate transport and their use in renal failure, etc.

May 29, 2002

Inhibitors of 5alpha-reductase highlighted at the AUA meeting

May 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...